BioSpace News Archive

Science Exchange announced today that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of DCAT beginning November 1, 2017.

ScandiDos AB and Varian Medical Systems have completed verification and validation of the Delta4 Discover system for use on TrueBeam and Clinac Ix radiotherapy systems [15-November-2017] UPPSALA, Sweden, Nov. 15, 2017 /PRNewswire/ -- ScandiDos AB (NASDAQ OMX First North: SDOS), a global leader in Quality Assurance (QA) and dosimetry for modern radiation thera

The Company will provide investors an update on recent and ongoing business activities and an overview of its 3Q17 financials on Monday, November 20th.

Net revenues were SEK 16.1 M (69.5 M).

The term of the issued patent extends to January 2035.

People who meet certain requirements are eligible to participate and may pay as little as $0 out-of-pocket.

The Company expects its shares will be accepted to trade on OTCQB under the symbol “MDVX” effective as early November 16, 2017.

Enrollment of the first cohort (Cohort A) is now complete. Participants in Cohort A received two CYP-001 infusions each at the lower dose level (1 million cells/kg, up to a maximum of 100 million cells per infusion).

Astra and MedImmune, today announced that the FDA has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Intezyne announced that its recently closed $10M Series A Preferred round, led by Gaston Capital, was recognized as the ‘Deal of the Year: Initial Funding’ at the 19th Annual Southeast BIO Investor & Partnering Forum, held in Pinehurst, NC from November 14-16, 2017.